Editas Medicine Inc

Financials

Flujo de caja de las actividades operativas -50.76 M-47.8 M-50.21 M-30.84 M-36.39 M -165.24 M Flujo de caja de las actividades de inversión 30.96 M56.39 M42.65 M39.57 M58 K 138.67 M Flujo de caja de las actividades financieras 55.51 M-1.44 M7.41 M17.17 M17.33 M 40.47 M Flujo de caja libre -51.3 M-47.91 M-50.21 M-31.28 M-36.45 M -165.85 M

Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

EDIT

Financials

Editas Medicine Inc

Noticias

Why Is Black Diamond (BDTX) Up 19.3% Since Last Earnings Report?

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Editas (EDIT) Up 3.8% Since Last Earnings Report: Can It Continue?

Editas Medicine nombra a PwC como nuevo auditor y prescinde de Ernst & Young

La oficina de patentes reafirma los derechos CRISPR del Broad Institute

EDIT Stock Up on Narrower-Than-Expected Q4 Loss, Revenues Rise Y/Y

Jones Trading mejora la calificación de Editas Medicine por avances en terapia génica

Jones Trading mejora calificación de Editas Medicine por avances en terapia

Jones Trading upgrades Editas Medicine stock rating on gene therapy progress

Baird reitera calificación de acciones de Editas Medicine por avances en pipeline

Baird reitera calificación de Editas Medicine por avance en pipeline

Baird reiterates Editas Medicine stock rating on pipeline progress